|
"kao j h"的相關文件
顯示項目 1246-1270 / 1534 (共62頁)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T08:38:36Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu, C.-H. ;Liang, C.-C. ;Huang, K.-W.; Liu, C.-J. ;Chen, S.-I.; Lin, J.-W. ;Hung, P.-H.; Tsai, H.-B. ;Lai, M.-Y. ;Chen, P.-J. ;Chen, J.-H. ;Chen, D.-S. ;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; KAI-WEN HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:52Z |
Epileptic seizure detection for multichannel EEG signals with support vector machines
|
Lin, J.-W.; Kao, J.-H.; Chen, C.-P.; Lai, F.; FEI-PEI LAI; Chiu, M.-J.; Shen, C.-P.;Chan, C.-M.;Lin, F.-S.;Chiu, M.-J.;Lin, J.-W.;Kao, J.-H.;Chen, C.-P.;Lai, F.; Shen, C.-P.; Chan, C.-M.; Lin, F.-S. |
| 臺大學術典藏 |
2018-09-10T08:30:13Z |
Treatment of hepatitis C virus infection in patients with end-stage renal disease
|
Liu, C.-H.;Kao, J.-H.; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:28:55Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang, J.-Y.;Liu, C.-H.;Hu, F.-C.;Chang, H.-C.;Liu, J.-L.;Chen, J.-M.;Yu, C.-J.;Lee, L.-N.;Kao, J.-H.;Yang, P.-C.; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Rifaximin treatment in hepatic encephalopathy [1]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed?
|
Sung, J.J.Y.;Amarapurkar, D.;Chan, H.L.Y.;Cheng, J.;Kao, J.-H.;Han, K.-H.;Piratvisuth, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Use of statins and gallstone risk [1]
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm
|
Kao, J.H.;Chen, S.L.;Ma, H.I.;Law, P.Y.;Tao, P.L.;Loh, H.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Letter to the editor
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Optimal management of hepatocellular carcinoma: Challenges and opportunities
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Outcomes of HCV treatment: Who does well and who does not?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Preoperative drainage in pancreatic cancer
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Clinical implications of hepatitis B virus variants
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
|
Lui, Y.Y.-N.;Tsoi, K.K.-F.;Wong, V.W.-S.;Kao, J.-H.;Hou, J.-L.;Teo, E.-K.;Mohamed, R.;Piratvisuth, T.;Han, K.-H.;Mihm, U.;Wong, G.L.-H.;Chan, H.L.-Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
From liver markers to life expectancy
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C infection and metabolic syndrome.
|
JIA-HORNG KAO; Hsu, C.S.;Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A novel antibody associated with autoimmune pancreatitis [4]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Carvedilol versus variceal band ligation for prevention of the first variceal bleed
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang, Y.-W.;Chayama, K.;Tsuge, M.;Takahashi, S.;Hatakeyama, T.;Abe, H.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Implications of hepatitis B virus genomic variations on treatment outcomes
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
顯示項目 1246-1270 / 1534 (共62頁)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
每頁顯示[10|25|50]項目
|
